This result indicated that CD117 might be used as a potential useful marker in differentiating IOPNs from the other IPMN subtypes and shed new light into the biology of these rare intraductal lesions. The gene discussed is KIT; the disease is pancreatic intraductal papillary-mucinous neoplasm.